UNSPSC 85713644: Revision of autologous tissue substitute in right metacarpocarpal joint, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in right metacarpocarpal joint, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0RWS37Z

UNSPSC 85713644 Revision of autologous tissue substitute in right metacarpocarpal joint, percutaneous approach is a Commodity code that shows little relevant recent activity under its nominal medical device scope. The six state and local opportunities posted under this code since mid-August 2026 are unrelated to orthopedic tissue revision: they encompass independent medical evaluation services for public safety pension boards, surgical carve-out benefits administration, occupational health surveillance, detention-facility emergency medicine, pharmacy benefit management, and temporary health professional staffing. None of these opportunities involve tissue substitutes, joint revision, or the orthopedic surgical procedure implied by the code's title. The code appears to have been misapplied to general medical and health administration services rather than implant-based orthopedic surgery or tissue engineering.

No state and local procurement activity directly aligned with the code's stated scope—autologous tissue revision in the metacarpocarpal joint—is evident in the recent opportunity record. The issuing bodies represented are a municipal retirement board (Phoenix), two cities (Long Beach and Seattle via WSDOT), a county juvenile probation department (Harris County), a county health consortium (Collier County), and a county health system (Santa Clara). Geographic distribution spans Arizona, California, Washington, Texas, and Florida, but the opportunities themselves do not support active procurement of the commodity described in the code's name. Business development professionals should verify whether this code has been properly indexed for state and local orthopedic device or tissue-engineering opportunities, or whether the mismatch signals a cataloging error rather than a viable procurement channel.